Back to Search
Start Over
A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
- Source :
-
Journal of Infectious Diseases . 2020 Supplement, Vol. 221, pS174-S183. 10p. - Publication Year :
- 2020
-
Abstract
- <bold>Background: </bold>Carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a major problem among nosocomial infections, and it is a serious threat to patients. The clinical characteristics and outcome of CRKP bloodstream infection (BSI) in nontransplant patients remains unelucidated. The aim of this study was as follows: identify the risk factors of CRKP infection; generate new ideas for prevention; and generate new ideas for the most effective therapeutic management in nontransplant patients.<bold>Methods: </bold>The study retrospectively analyzed the clinical and microbiological data of nontransplant patients with K pneumoniae (KP) bacteremia from January 2013 to December 2015 to identify risk factors, clinical features, and outcomes using multivariate logistic regression analysis.<bold>Results: </bold>Of the 371 patients with KP-BSI in nontransplant patients included in this study, 28.0% (N = 104) had CRKP. The 28-day mortality was higher in patients infected with CRKP (55.8%) than in those with carbapenem-susceptible KP (13.9%) (P < .001). Multivariate analysis showed previous gastric catheterization, previous use of carbapenems, hypoproteinemia, and high Acute Physiologic Assessment and Chronic Health Evaluation II scores as independent risk factors for CRKP-BSIs. Carbapenem-resistant KP infection, severe illness, and tigecycline therapy were independent risk factors for death from KP-BSIs. Taken together, inappropriate antibiotic treatment both in empirical and definitive therapy and imipenem minimum inhibitory concentrations (MICs) of >8 mg/L were associated with poor clinical outcome.<bold>Conclusions: </bold>Nontransplant patients with CRKP-BSI had higher mortality. Carbapenems exposure was an independent risk factor for CRKP infection. Imipenem MICs of >8 mg/L, tigecycline therapy, and inappropriate treatments increased the 28-day mortality of KP-BSI patients. [ABSTRACT FROM AUTHOR]
- Subjects :
- *CARBAPENEM-resistant bacteria
*KLEBSIELLA pneumoniae
*FACTOR analysis
*RISK assessment
*BACTEREMIA
*BACTEREMIA diagnosis
*KLEBSIELLA
*RESEARCH
*TIME
*MULTIVARIATE analysis
*RESEARCH methodology
*RETROSPECTIVE studies
*EVALUATION research
*MEDICAL cooperation
*KLEBSIELLA infections
*COMPARATIVE studies
*SURVIVAL analysis (Biometry)
*CARBAPENEMS
*DRUG resistance in microorganisms
*MICROBIAL sensitivity tests
*ANTIBIOTICS
*PHARMACODYNAMICS
Subjects
Details
- Language :
- English
- ISSN :
- 00221899
- Volume :
- 221
- Database :
- Academic Search Index
- Journal :
- Journal of Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 142313792
- Full Text :
- https://doi.org/10.1093/infdis/jiz559